Ayelet Zafran

Ayelet Zafran is the Vice President of Research and Development at Nanocarry Therapeutics, a position held since December 2022, and previously served as a Senior Scientist. Prior experience includes roles as a Bioprocess Scientist and Scientist at Teva Pharmaceuticals from January 2020 to December 2022, as well as a Senior Scientist at Beta-o2 for a brief period in 2019. Ayelet Zafran also worked as a Teaching Assistant at Tel Aviv University from 2010 to 2017. Academic credentials include a PhD in Cancer Biophysics, an MSc in Neuroscience, and a BSc in Life Science, all from Tel Aviv University, with studies completed between 2005 and 2018.